Breath test to predict COPD flare-ups
Part of Lungs & breathing clinical trials.
This study looks at how a simple breath test (measuring nitric oxide in the air you breathe out) might help predict when COPD symptoms flare up. If you take triple inhaler therapy, this study could help you and your doctor better manage your condition and prevent future flare-ups.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 40 years old or older.
- You must have a confirmed diagnosis of COPD (chronic lung disease that makes it hard to breathe).
- You must have a history of cigarette smoking.
- You must be taking triple inhaler therapy (three different inhaled medicines combined) or be prescribed it now.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new treatment for people with COPD who still have frequent flare-ups despite using two maintenance inhalers. It aims to see if the study medicine can reduce these flare-ups.
This trial tests whether a gas called nitric oxide, breathed in through the nose or mouth, can help people with moderate to severe COPD. It could improve breathing and quality of life.
This study looks at whether a breathing test called oscillometry can help guide treatment when switching from two inhaled medicines to triple therapy (including a steroid) for people with COPD who often have flare-ups.
This study tests a new approach to reduce flare-ups (sudden worsening of symptoms) in people with COPD. If you've had frequent flare-ups, this trial may help you manage your condition better.
This study looks at factors that can predict when chronic obstructive pulmonary disease (COPD) will flare up. It may help doctors identify people at higher risk sooner and tailor care to prevent flare-ups.
This study tests whether a structured care program for COPD can lower how often your symptoms flare up. It may help by improving everyday management and preventing future worsening.
Hear when a new Chronic Obstructive Pulmonary Disease (COPD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.